IP Library Granted Patent US 6,855,749
Granted Patent B1
US 6,855,749 · App. 10/449,281 · Granted Feb 15, 2005

Polymer nanocomposite implants with enhanced transparency and mechanical properties for administration within humans or animals

Assignee: NanoProducts Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,855,749
App. No.
10/449,281
Granted
Feb 15, 2005
Kind
B1
Abstract

Polymer nanocomposite implants with nanofillers and additives are described. The nanofillers described can be any composition with the preferred composition being those composing barium, bismuth, cerium, dysprosium, europium, gadolinium, hafnium, indium, lanthanum, neodymium, niobium, praseodymium, strontium, tantalum, tin, tungsten, ytterbium, yttrium, zinc, and zirconium. The additives can be of any composition with the preferred form being inorganic nanopowders comprising aluminum, calcium, gallium, iron, lithium, magnesium, silicon, sodium, strontium, titanium. Such nanocomposites are particularly useful as materials for biological use in applications such as drug delivery, biomed devices, bone or dental implants.

Claims (31)

1. A nanocomposite for administration in a human or animal comprising:

an acrylate matrix;

nanofillers comprising one or more elements selected from the group: barium, bismuth, cerium, dysprosium, europium, gadolinium, hafnium, indium, lanthanum, neodymium, niobium, praseodymium, strontium, tantalum, tin, tungsten, ytterbium, yttrium, zinc, and zirconium;

wherein the nanofillers have a domain size less than 100 nanometers;

wherein the nanofillers are mixed into the acrylate matrix at a loading of less than 80 volume percent to form a nanocomposite; and

wherein the composite exhibits a transparency to light that differs by more than 20% as compared with the transparency to light exhibited by a composite of similar composition with fillers having a domain size of at least one micron.

2. The nanocomposite of claim 1 wherein secondary species are added to the matrix.

3. The nanocomposite of claim 2 wherein the secondary species comprise dispersants, binders, modifiers, detergents, and additives.

4. The nanocomposite of claim 3 wherein the additives comprise nanopowders.

5. The nanocomposite of claim 4 wherein the nanopowders comprise at least one element selected from the group: aluminum, calcium, gallium, iron, lithium, magnesium, silicon, sodium, strontium, titanium, and boron.

6. The nanocomposite of claim 4 wherein the nanopowders have a composition that comprises two or more elements selected from the group; aluminum, barium, calcium, cerium, gallium, iron, lithium, magnesium, potassium, silicon, sodium, strontium, titanium, tin, zirconium, carbon, oxygen and boron.

7. The nanocomposite of claim 1 wherein the nanofillers are coated.

8. A nanocomposite for administration in a human or animal comprising:

a polymer matrix;

nanofillers comprising one or more elements selected from the group: barium, bismuth, cerium, dysprosium, europium, gadolinium, hafnium, indium, lanthanum, neodymium, niobium, praseodymium, strontium, tantalum, tin, tungsten, ytterbium, yttrium, zinc, and zirconium;

a secondary species comprising metal oxide nanopowder additives;

wherein the nanopowder additives comprise at least one element selected from the group consisting of: aluminum, calcium, gallium, iron, lithium, magnesium, silicon, sodium, strontium, titanium, carbon, oxygen and boron;

wherein the nanofillers have a domain size less than 100 nanometers; and

wherein the nanofillers are mixed into the polymer matrix at a loading of less than 95 volume percent to form a nanocomposite.

9. The nanocomposite of claim 8 wherein the nanofillers are surface treated.

10. The nanocomposite of claim 9 wherein the surface treatment comprises treatment of the nanofillers with acid or base.

11. The nanocomposite of claim 8 wherein the nanofillers are coated.

12. A product incorporating the nanocomposite of claim 1 .

13. A product incorporating the nanocomposite of claim 8 .

14. An implant for administration in a human or animal comprising the nanocomposite of claim 1 .

15. An implant for administration in a human or animal comprising the nanocomposite of claim 8 .

16. A nanocomposite for administration in a human or animal comprising:

a polymer matrix;

oxide nanofillers comprising two or more elements selected from the group; barium, strontium, yttrium, tantalum, tin, titanium, silver, aluminum, silicon, zinc and zirconium;

wherein the nanofillers have a domain size less than 100 nanometers; and

wherein the nanofillers are mixed into the polymer matrix at a loading of less than 95 volume percent to form a nanocomposite.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2008
From: NANOPRODUCTS CORPORATION
To: PPG INDUSTRIES OHIO, INC.
Reel/Frame 020540/0506 →
RELEASE OF SECURITY INTEREST Recorded Jan 29, 2008
From: KOCH NANOMATERIALS, LLC, BY KOCH GENESIS COMPANY, LLC
To: NANOPRODUCTS CORPORATION
Reel/Frame 020417/0791 →
SECURITY AGREEMENT Recorded Jun 27, 2007
From: NANOPRODUCTS CORPORATION
To: KOCH NANOMATERIALS, LLC, BY KOCH GENESIS COMPANY, LLC
Reel/Frame 019477/0836 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 3, 2005
From: YADAV, DR. TAPESH; KOSTELECKY, CLAYTON; FRANKE, EVAN; MIREMADI, BIJAN; AU, MING
To: NANOPRODUCTS CORPORATION
Reel/Frame 015508/0062 →
Continuity (9)
Division 0979003600 · Feb 20, 2001
Division 0908389300 · May 22, 1998
Continuation In Part 0873925700 · Oct 30, 1996
Continuation In Part 0873066100 · Oct 11, 1996
Continuation In Part 0870681900 · Sep 3, 1996
Continuation In Part 0870734100 · Sep 3, 1996
Provisional Application 6007922500 · Mar 24, 1998
Provisional Application 6006993600 · Dec 17, 1997
Provisional Application 6004907700 · Jun 9, 1997